Current Report Filing (8-k)
June 08 2017 - 09:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): June 8, 2017
Amedica
Corporation
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-33624
|
|
84-1375299
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1885
West 2100 South
Salt
Lake City, UT
|
|
84119
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(801) 839-3500
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
8.01 Other Events.
On
June 8, 2017, Amedica Corporation issued a preliminary earnings report for the fourth quarter and fiscal year ended December 31,
2016 and provided a business update related to its business strategy and certain recent developments. A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
|
Exhibits
.
|
|
|
99.1
|
Amedica
Corporation Press Release dated June 8, 2017.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
AMEDICA
CORPORATION
|
|
|
Date:
June 8, 2017
|
/s/
B. Sonny Bal
|
|
B.
Sonny Bal, MD
|
|
Chief
Executive Officer
|
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Feb 2024 to Mar 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Mar 2023 to Mar 2024